CA2959800A1 - Forme galenique a macher semi-solide pour medicaments en vente libre et procedes pour la produire - Google Patents
Forme galenique a macher semi-solide pour medicaments en vente libre et procedes pour la produire Download PDFInfo
- Publication number
- CA2959800A1 CA2959800A1 CA2959800A CA2959800A CA2959800A1 CA 2959800 A1 CA2959800 A1 CA 2959800A1 CA 2959800 A CA2959800 A CA 2959800A CA 2959800 A CA2959800 A CA 2959800A CA 2959800 A1 CA2959800 A1 CA 2959800A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- dosage form
- amount
- semi
- blend
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462046712P | 2014-09-05 | 2014-09-05 | |
US62/046,712 | 2014-09-05 | ||
US201562115618P | 2015-02-12 | 2015-02-12 | |
US62/115,618 | 2015-02-12 | ||
US14/626,897 US20160067340A1 (en) | 2014-09-05 | 2015-02-19 | Semi-solid chewable dosage form for over-the-counter medications and method for producing same |
US14/626,897 | 2015-02-19 | ||
PCT/US2015/049000 WO2016037189A1 (fr) | 2014-09-05 | 2015-09-08 | Forme galénique à mâcher semi-solide pour médicaments en vente libre et procédés pour la produire |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2959800A1 true CA2959800A1 (fr) | 2016-03-10 |
Family
ID=55440441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2959800A Abandoned CA2959800A1 (fr) | 2014-09-05 | 2015-09-08 | Forme galenique a macher semi-solide pour medicaments en vente libre et procedes pour la produire |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3188718A1 (fr) |
AU (1) | AU2015311657A1 (fr) |
CA (1) | CA2959800A1 (fr) |
MX (1) | MX2017002897A (fr) |
WO (1) | WO2016037189A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018236990A1 (fr) * | 2017-06-20 | 2018-12-27 | Seattle Gummy Company | Compositions gommeuses à base de gélatine et leurs procédés de production et d'utilisation |
CN107334747A (zh) * | 2017-07-25 | 2017-11-10 | 东莞云森生物医药科技有限公司 | 一种预防晕动症的口香糖 |
CN112822998B (zh) | 2018-10-18 | 2024-09-13 | 强生消费者公司 | 新型剂型 |
CN109925289B (zh) * | 2019-04-11 | 2021-05-25 | 海南普利制药股份有限公司 | 地氯雷他定分散片 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
ES2302926T5 (es) * | 2002-04-25 | 2012-08-23 | Banner Pharmacaps, Inc. | Cápsula blanda masticable |
US20070292501A1 (en) * | 2006-06-05 | 2007-12-20 | Udell Ronald G | Chewable soft gelatin capsules |
-
2015
- 2015-09-08 EP EP15767000.1A patent/EP3188718A1/fr not_active Withdrawn
- 2015-09-08 WO PCT/US2015/049000 patent/WO2016037189A1/fr active Application Filing
- 2015-09-08 MX MX2017002897A patent/MX2017002897A/es unknown
- 2015-09-08 CA CA2959800A patent/CA2959800A1/fr not_active Abandoned
- 2015-09-08 AU AU2015311657A patent/AU2015311657A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2015311657A1 (en) | 2017-03-23 |
EP3188718A1 (fr) | 2017-07-12 |
WO2016037189A1 (fr) | 2016-03-10 |
MX2017002897A (es) | 2018-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3641774B1 (fr) | Composition gélifiée à base de pectine et leurs procédés de fabrication et d'utilisation | |
JP5539503B2 (ja) | 不快味を効果的に隠蔽した経口用速溶フィルム | |
US20170209370A1 (en) | Semi-solid chewable dosage form for over-the-counter medications and method for producing same | |
JP5941558B2 (ja) | シルデナフィルを有効成分として含有し、且つ、苦味の隠蔽された高含量速溶フィルム | |
US5958445A (en) | Oral Formulations of S(+)-etodolac | |
CA2959800A1 (fr) | Forme galenique a macher semi-solide pour medicaments en vente libre et procedes pour la produire | |
TWI605837B (zh) | Pharmaceutical composition containing water-insoluble drug and pharmaceutical preparation | |
Jadhav et al. | Challenges in formulation development of fast dissolving oral films | |
Gopale et al. | Medicated Lozenges: A Review: Artificial intelligence in drug discovery | |
JP2006028028A (ja) | 経口医薬組成物 | |
JP6365235B2 (ja) | 液状組成物 | |
US20170209369A1 (en) | Semi-solid chewable dosage form for over-the-counter medications and method for producing same | |
JP2023525277A (ja) | 口腔ケア利益のための洗口剤 | |
JP5491943B2 (ja) | ビタミンb1類含有経口ゼリー剤 | |
EP1401403B1 (fr) | Compositions medicamenteuses comprenant un noyau fondant encapsule dans un film d'hydroxypropylmethylcellulose | |
KR101736038B1 (ko) | 항히스타민을 포함하는 약용 츄잉껌 제제 | |
JP2017160192A (ja) | 経口製剤 | |
JP2005139173A (ja) | ビグアナイド系薬剤を含有するゼリー製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |
Effective date: 20200909 |